WARSAW, Ind., April 28 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. , an independent provider of products to the global orthopedic device industry, today announced the results of the board member elections at its 2006 Annual Meeting of Stockholders held on April 27, 2006.
Stephen B. Oresman and Frank Turner were re-elected to the Board of Directors to serve a three year term as Class I Directors, and James Burns was elected to the Board of Directors as a Class II Director to serve a one year term. At the organizational meeting of the Board of Directors, Frank Turner was elected to serve as Chairman of the Board of Directors.
About Symmetry Medical Inc.
Symmetry Medical Inc. is an independent provider of implants and related instruments and cases to the orthopedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including dental, osteobiologic and endoscopy sectors and provides limited specialized products and services to non- healthcare markets, such as the aerospace market.
Forward Looking Statements
Statements in this press release regarding Symmetry Medical Inc.'s business, which are not historical facts may be "forward-looking statements" that involve risks and uncertainties. Forward-looking statements frequently are identified by the use of terms such as "may," "will," "should," "expect," "believe," "estimate," "intend" and similar words indicating possible future expectations, events or actions. Such predictive statements are not guarantees of future performance, and actual results could differ materially from our current expectations. Certain factors that could cause actual results to differ include: the loss of one or more customers; the development of new products or product innovations by our competitors; product liability; changes in management; changes in conditions affecting the economy, orthopedic device manufacturers or the medical device industry generally; and changes in government regulation of medical devices and third-party reimbursement practices. For a discussion of these and other risks and uncertainties that could cause actual results to differ from those contained in the forward- looking statements, we refer you to the Company's Annual Report filed on Form 10-K, which contains a detailed explanation of the many risk factors as well as the Company's other filings with the Securities and Exchange Commission, which are available on the SEC's website at www.sec.gov. All forward-looking statements are qualified in their entirety by this cautionary statement, and Symmetry Medical Inc. undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof.
Investors/Media: Contact: The Ruth Group Symmetry Medical Inc. Stephanie Carrington/Jason Rando Andrew Miclot 646-536-7017/7025 Senior Vice President scarrington@theruthgroup.com Marketing, Sales & Business Development jrando@theruthgroup.com Investor Relations Officer 574-269-7390 ext. 1002
Symmetry Medical Inc.CONTACT: Stephanie Carrington, +1-646-536-7017,scarrington@theruthgroup.com, or Jason Rando, +1-646-536-7025,jrando@theruthgroup.com, both of The Ruth Group; Andrew Miclot, Senior VicePresident, Marketing, Sales & Business Development, Investor RelationsOfficer of Symmetry Medical Inc., +1-574-269-7390 ext. 1002
